Showing 2894 results
-
Event /Novartis announced the company’s financial results for the third quarter of 2019.
-
Story /Novartis researchers aim to quash inflammation to treat chronic disease.
-
Story /Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.
-
Story /Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.
-
Press release /NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in younger patients Pluvicto analysis and Scemblix ASC4START primary endpoint results…
-
Statement /
-
Press release /Reduction in distant recurrence consistently deepened beyond 3-year Kisqali treatment duration in patients with node-positive (N+) and high-risk node-negative (N0) disease, as well as between…